MedTrace Logo

The SIMBA Project - The Effect of a Prebiotic Supplement on Glucose Metabolism and Gut Microbiota in Obese Adults

NCT04120051 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-11-05

No results posted yet for this study

Summary

Modulation of the gut microbiota via administration of pro- and prebiotics have been proposed to contribute to weight loss and reduce plasma glucose and serum lipid levels, improving the inflammatory state and decreasing the incidence of type 2 diabetes and cardiovascular disease. This study will test a fermented canola-seaweed (FCS) product, high in glucosinolates and putatively prebiotic oligosaccharides, in human subjects with obesity.

Conditions

  • Glucose Metabolism
  • Metabolic Syndrome
  • Gut Microbiota

Interventions

DIETARY_SUPPLEMENT

Fermented canola-seaweed

A daily sachet with 5 gram FCS-granulate for 6 weeks

OTHER

Placebo

A daily sachet with 5 gram rye cereal for 6 weeks

Sponsors & Collaborators

  • FermBiotics ApS

    collaborator UNKNOWN

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Mads V Lind, PhD · University of Copenhagen, Department of Nutrition, Exercise and Sports

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-28
Primary Completion
2020-03-31
Completion
2020-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04120051 on ClinicalTrials.gov